نتایج جستجو برای: candesartan

تعداد نتایج: 1372  

2008
S. S. Qutab S. N. Razzaq M. Ashfaq Z. A. Shuja I. U. Khan

A simple, sensitive, and inexpensive high-performance liquid-chromatographic method has been developed for simultaneous determination of hydrochlorothiazide and candesartan cilexetil in pharmaceutical formulations. Chromatographic separation was achieved on a Phenyl-2 column with a 25:75:0.2 mixture of 0.02 M potassium dihydrogen phosphate, methanol, and triethylamine, final pH 6.0 ± 0.1, as mo...

Journal: :Hypertension 2008
Jan W Eriksson Per-Anders Jansson Bo Carlberg Anders Hägg Lisa Kurland Maria K Svensson Håkan Ahlström Conny Ström Lars Lönn Kristina Ojbrandt Lars Johansson Lars Lind

Treatment with angiotensin II receptor blockers is associated with lower risk for the development of type 2 diabetes mellitus compared with thiazide diuretics. The Mechanisms for the Diabetes Preventing Effect of Candesartan Study addressed insulin action and secretion and body fat distribution after treatment with candesartan, hydrochlorothiazide, and placebo. Twenty-six nondiabetic, abdominal...

Journal: :Thorax 2004
M Otsuka H Takahashi M Shiratori H Chiba S Abe

BACKGROUND Signalling of angiotensin II via angiotensin II type 1 receptor (AT1) promotes cardiac and renal fibrosis, but its role in lung fibrosis is little understood. Using a rat bleomycin (BLM) induced model of pulmonary fibrosis, we examined the expression of AT1 in the lung and the effect of an AT1 antagonist on pulmonary fibrosis. METHODS Adult male Sprague-Dawley rats were given 0.3 m...

Journal: :American journal of physiology. Renal physiology 2010
Rifat Sabuhi Mohammad Asghar Tahir Hussain

A positive association between renin-angiotensin system, especially AT1 receptor, and oxidative stress in the pathogenesis of hypertension and cardiovascular/renal diseases has been suggested. However, the role of oxidative stress, especially superoxide radicals in renal sodium handling in response to AT1 and AT2 receptors, is not known. Therefore, the present study was designed to investigate ...

Journal: :Hypertension 2005
Damiano Rizzoni Enzo Porteri Carolina De Ciuceis Intissar Sleiman Luigi Rodella Rita Rezzani Silvia Paiardi Rossella Bianchi Giuseppina Ruggeri Gianluca E M Boari Maria Lorenza Muiesan Massimo Salvetti Francesca Zani Marco Miclini Enrico Agabiti Rosei

Structural alterations of subcutaneous small resistance arteries are associated with a worse clinical prognosis in hypertension and noninsulin-dependent diabetes mellitus (NIDDM). However, no data are presently available about the effects of antihypertensive therapy on vascular structure in hypertensive patients with NIDDM. Therefore, we have investigated the effect of an angiotensin-converting...

Journal: :American journal of physiology. Renal physiology 2009
Sophie C Lütken Soo Wan Kim Thomas Jonassen David Marples Mark A Knepper Tae-Hwan Kwon Jørgen Frøkiaer Søren Nielsen

Heart failure (HF) was induced by ligation of the left anterior descending artery (LAD). Left ventricular end-diastolic pressure (LVEDP) >25 mmHg (at day 23 after LAD ligation) was the inclusion criterion. The rats were divided into three groups: sham-operated (Sham, n = 23, LVEDP: 5.6 +/- 0.6 mmHg), HF (n = 14, LVEDP: 29.4 +/- 1.4 mmHg), and candesartan (1 mg.kg(-1).day(-1) sc)-treated HF (HF ...

Journal: :Hypertension research : official journal of the Japanese Society of Hypertension 2003
Hiroto Matsuda Koichi Hayashi Koichiro Homma Kyoko Yoshioka Takeshi Kanda Ichiro Takamatsu Satoru Tatematsu Shu Wakino Takao Saruta

It has becoming clear that angiotensin receptor blockers (ARBs) show varying levels of angiotensin II type 1 (AT1) receptor blocking activity. Although the duration of activity and the efficacy on blood pressure of ARB are reported to vary, depending on the agents used, it has not been examined whether the effects on proteinuria and urinary nitrite/nitrate (NOx) excretion differ in hypertensive...

Journal: :European heart journal 2009
Jan A Staessen Tom Richart Willem H Birkenhäger

In the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Heart Disease (HIJ-CREATE), Kasanuki and colleagues randomized hypertensive patients with angiographically proven coronary heart disease either to candesartan or to blood pressure-lowering treatment not based on an angiotensin II type-1 receptor blocker (ARB), but possibly including an angiotensin-converting...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید